Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/04/2857500/0/en/EnteroBiotix-Completes-27m-Financing-Round-to-Advance-Clinical-Trials.html
https://www.globenewswire.com/news-release/2024/04/03/2856635/0/en/EnteroBiotix-Initiates-Phase-2-Study-of-EBX-102-02-in-Patients-with-Irritable-Bowel-Syndrome-IBS.html
https://www.globenewswire.com//news-release/2024/02/01/2821719/0/en/EnteroBiotix-Strengthens-its-Executive-Team-Appoints-COO-and-CFO.html
https://www.globenewswire.com/news-release/2023/07/17/2705236/0/en/EnteroBiotix-appoints-Elmar-Schnee-as-Executive-Chairman.html
https://www.globenewswire.com/news-release/2023/03/28/2635376/0/en/EnteroBiotix-Initiates-Phase-2-study-of-microbiome-drug-EBX-102-in-liver-cirrhosis-and-hepatic-encephalopathy.html
https://www.pharmatimes.com/news/enterobiotix_announces_partnership_with_imperial_college_london_1480617
https://www.prnewswire.com/news-releases/enterobiotix-partners-with-imperial-college-london-to-develop-microbiome-therapeutics-301672704.html
https://www.pharmiweb.com/press-release/2022-10-11/enterobiotix-receives-mhra-mia-imp-licensure-of-state-of-the-art-gmp-manufacturing-facility-for-producing-microbiome-therapeutics